Bendamustine and rituximab and lenalidomide (BRR) in the treatment of relapsed and refractory low grade non-Hodgkin lymphoma (NHL): Final results of phase 1 study NCCTG N1088/Alliance
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 8540
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3596
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Grzegorz S. Nowakowski Betsy LaPlant William R. Macon Morie A. Gertz Thomas M. Habermann David J. Inwards Ivana N. Micallef Donald B. Wender John P. Leonard Thomas E. Witzig
- Networks:
- LAPS-MN026, NY018, SANFORD
- Study
- NCCTG-N1088
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords: